Influence of hypercholesterolemia and hypertension on the integrity of the blood-brain barrier in rats

International Journal of Neuroscience

Volumn 119, Issue 10, 2009, Pages 1881-1904

  Kalayci, Rivaze ^a   Kaya, Mehmet ^a,b   Uzun, Hafize ^c   Bilgic, Bilge ^b   Ahishali, Bülent ^b   Arican, Nadir ^b   Elmas, Imdat ^a,b   Kücük, Mutlu ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Blood brain barrier; Glial fibrillary acidic protein; Hypercholesterolemia; Hypertension; Nitric oxide; Occludin; VEGF; ZO 1

Indexed keywords

ANGIOTENSIN II; CATALASE; CHOLESTEROL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; MALONALDEHYDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OCCLUDIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN ZO1; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN TISSUE; CELL ACTIVITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOREACTIVITY; LIPOPROTEIN BLOOD LEVEL; MALE; MICROVASCULATURE; NONHUMAN; OXIDATION; PERIPHERAL VASCULAR SYSTEM; RAT; TIGHT JUNCTION; VASCULAR ENDOTHELIUM;

ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; BLOOD-BRAIN BARRIER; BODY WEIGHT; CATALASE; CHOLESTEROL; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; MEMBRANE PROTEINS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PHOSPHOPROTEINS; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70350443610     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/14647270802336650     Document Type: Article

References (54)

1. Ahishali, B., Kaya, M., Kalayci, R., H. Uzun, B., Bilgic, N., Arican, I., et al. (2005). Effects of lipopolysaccharide on the blood-brain barrier permeability in prolonged nitric oxide blockade-induced hypertensive rats. International Journal of Neuroscience, 115, 211-228.
2. Akao, S., & Kiumi, F. (2002). The tight junction of main pancreatic duct epithelial cells is a morphometrically dynamic structure altered by intraductal hypertension. Medical Electron Microscopy, 45, 146-152.
3. Baylis, C., Mitruka, B.,&Deng, A. (1992). Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. Journal Clinical Investigation, 90, 278-281.
4. Beckman, J. S., & Koppenol,W. H. (1996). Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. American Journal of Physiology, 271, C1424-C1437.
5. Belgore, F. M., Lip, G. Y., & Blann, A. D. (2000). Successful therapy reduces levels of vascular endothelial growth factor (VEGF) in patients with hypertension and patients with hypercholesterolemia. Atherosclerosis, 151, 599.
6. Beuge, J. A.,&Aust, S. D. (1978).Microsomal lipid peroxidation. Method Enzymology, 53, 302-310.
7. Beutler, E., Duron, O., & Kelly, M. B. (1963). Improved method for the determination of blood glutathione. Journal Laboratory Clinical Medicine, 6, 882-888.
8. Blot, S., Arnal, J. F., Xu, Y., Gray, F., & Michel, J. B. (1994). Spinal cord infarcts during long-term inhibition of nitric oxide synthase in rats. Stroke, 25, 1666-1673.
9. Bolton, S. J., Anthony, D. C., & Perry, V. H. (1998). Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience, 86, 1245-1257.
10. Bonetti, P. O., Wilson, S. H., Rodriguez-Porcel, M., Jr., Holmes, D. R., Lerman, L. O., & Lerman, A. (2002). Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid lowering. Journal of American Collage of Cardiology, 40, 546-554. (Pubitemid 34833173)
11. Clarkson, P.,Celermajer, D. S.,Donald,A.E., Sampson, M., Sorensen, K. E.,Adams,M., et al. (1996). Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. Journal American Collage Cardiology, 28, 573-579.
12. Croll, S. D., Ransohoff, R. M., Cai, N., Zhang, Q., Martin, F. J., Wei, T., et al. (2004). VEGF-mediated inflammation precedes angiogenesis in adult brain. Experimental Neurology, 187, 388-402.
13. Demchuk, A. M., Hess, D. C., Brass, L. M., & Yatsu, F. M. (1999). Is cholesterol a risk factor for stroke?: Yes. Archives of Neurology, 56, 1518-1520.
14. Dvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F., & Dvorak, A. M. (1999). Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Current Topics in Microbiology and Immunology, 237, 97-132. (Pubitemid 28554861)
15. Eryurek, F. G., Surmen, E., Oner, P., Altug, T., & Oz, H. (1990). Gamma-glutamyl transpeptidase and acetylcholinesterase activities in brain capillaries of cholesterolfed rabbits. Research Communications in Chemical Pathology & Pharmacology, 69, 245-248.
16. Feltkamp, C. A.,&Van DerWaerden, A.W. (1983). Junction formation between cultured normal rat hepatocytes. An ultrastructural study on the presence of cholesterol and the structure of developing tight-junction strands. Journal of Cell Science, 63, 271-286.
17. Fukai, T., Siegfried, M. R., Ushio-Fukai, M., Cheng, Y., Kojda, G., & Harrison, D. G. (2000). Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. Journal of Clinical Investigation, 105, 1631-1639.
18. Granger, D. N. (1999). Ischemia-reperfusion: Mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculation, 6, 167-178.
19. Henry, G. D., Byrne, R., Hunyh, T. T., Abraham, V., Annex, B. H., Hagen, P. O., et al. (2000). Intracavernosal injections of vascular endothelial growth factor protects endothelial dependent corpora cavernosal smooth muscle relaxation in the hypercholesterolemic rabbit: A preliminary study. International Journal of Impotence Research, 12, 334-339.
20. Hori, S., Ohtsuki, S., Hosoya, K., Nakashima, E., & Terasaki, T. (2004). A pericytederived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie-2 activation in vitro. Journal of Neurochemistry, 89, 503-513.
21. Hsieh, N. K.,Wang, J. Y., Liu, J. C., Lee,W. H.,&Chen, H. I. (2004). Structural changes in cerebral arteries following nitric oxide deprivation: A comparison between normotensive and hypertensive rats. Journal of Thrombosis and Haemostasis, 92, 162-170.
22. Ishikawa,M., Stokes, K. Y., Zhang, J. H., Nanda, A., & Granger, D. N. (2004). Cerebral microvascular responses to hypercholesterolemia: Roles of NADPH oxidase and P-selectin. Circulation Research, 94, 239-244.
23. Johansson, B. B. (1998). Hypertension. In W. M. Pardridge (ed.), Introduction to the Blood-Brain Barrier Methodology, Biology and Pathology. Cambridge: Cambridge University Press, 427-433.
24. Kalayci, R., Kaya, M., Elmas, I., Arican, N., Ahishali, B., Uzun, H., et al. (2005). Effects of atorvastatin on blood-brain barrier permeability during L-NAME hypertension followed by angiotensin-II in rats. Brain Research, 1042, 184-193.
25. Kang, D. H., Nakagawa, T., Feng, L., & Johnson, R. J. (2002). Nitric oxide modulates vascular disease in the remnant kidney model. American Journal of Pathology, 161, 239-248.
26. Kaya, D., Gursoy-Ozdemir, Y., Yemisci, M., Tuncer, N., Aktan, S., & Dalkara, T. (2005).VEGFprotects brain against focal ischemia without increasing blood-brain permeability when administered intracerebroventricularly. Journal of Cerebral Blood Flow & Metabolism, 13, 1-8.
27. Krum, J. M., Mani, N., & Rosenstein, J. M. (2002). Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience, 110, 589-604.
28. Kucuk, M., Kaya, M., Kalayci, R., Cimen, V., Kudat, H., Arican, N., et al. (2002). Effects of losartan on the blood-brain barrier permeability in longterm nitric oxide blockade-induced hypertensive rats. Life Sciences, 71, 937-946.
29. Lambert,D., O'Neill, C. A.,&Padfield, P. J. (2005). Depletion of Caco-2 cell cholesterol disrupts barrier function by altering the detergent solubility and distribution of specific tight-junction proteins. Biochemical Journal, 387, 553-560.
30. Laursen, H., & Diemer, N. H. (1980). Morphometry of astrocyte and oligodendrocyte ultrastructure after portocaval anastomosis in the rat. Acta Neuropathology (Berlin), 51, 65-70.
31. Lee, N. P., & Cheng, C. Y. (2004). Nitric oxide/nitric oxide synthase, spermatogenesis, and tight junction dynamics. Biology of Reproduction, 70, 267-276.
32. Liedtke, W., Edelmann, W., Bieri, P. L., Chiu, F. C., Cowan, N. J., Kucherlapati, R., et al. (1996). GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron, 17, 607-615.
33. Matsuda, A., Suzuki, Y., Kondo, K., Ikeda, Y., & Umemura, K. (2002). Hypercholesterolemia induces regression in neointimal thickening due to apoptosis of vascular smooth muscle cells in the hamster endothelial injury model. Cardiovascular Research, 53, 512-523.
34. Mayhan, W. G. (1995). Role of nitric oxide in disruption of the blood-brain barrier during acute hypertension. Brain Research, 686, 99-103.
35. Mayhan, W. G. (2000). Inhibition of nitric oxide synthase does not alter permeability of the blood-brain barrier. Brain Research, 855, 143-149.
36. Meyer, T. N., Schwesinger, C.,Ye, J., Denker, B. M.,&Nigam, S.K. (2001).Reassembly of the tight junction after oxidative stress depends on tyrosine kinase activity. Journal of Biological Chemistry, 276, 22048-22055.
37. Moncada, S., Palmer, R. M., & Higgs, E. A. (1991). Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacological Review, 43, 109-142.
38. Murohara, T., Horowitz, J. R., Silver, M., Tsurumi, Y., Chen, D., Sullivan, A., et al. (1998). Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation, 97, 99-107.
39. Nunnari, J. J., Fisher, M., & White, S. D. (1992). Inhibition of lipid deposition in the hypercholesterolemic rat by clentiazem, a calcium channel blocker. Experimental Molecular Pathology, 57, 193-204.
40. O'Donnell, V. B., & Freeman, B. A. (2001). Interactions between nitric oxide and lipid oxidation pathways: Implications for vascular disease. Circulation Research, 88, 12-21.
41. Panza, J. A. (1997). Endothelial dysfunction in essential hypertension. Clinical Cardiology, 20, 26-33.
42. Poritz, L. S., Garver, K. I., Tilberg, A. F., & Koltun,W. A. (2004). Tumor necrosis factor alpha disrupts tight junction assemble. Journal of Surgical Research, 116, 14-18.
43. Prado, R.,Watson, B. D.,Kuluz, J.,&Dietrich,W. D. (1992). Endothelium-derived nitric oxide synthase inhibition. Effects on cerebral blood flow, pial artery diameter, and vascular morphology in rats. Stroke, 23, 1118-1123.
44. Prasad, K. (1999). Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation, 99, 1355-1362.
45. Rodriguez-Porcel, M., Lerman, A., Herrmann, J., Schwartz, R. S., Sawamura, T., Condorelli, M., et al. (2003). Hypertension exacerbates the effect of hyperc-holesterolemia on the myocardial microvasculature. Cardiovascular Research, 58, 213-221.
46. Rumbaut,R.E., McKay,M.K.,&Huxley,V.H. (1995).Capillary hydraulic conductivity is decreased by nitric oxide synthase inhibition. American Journal of Physiology, 268, H1856-H1861.
47. Sato, J., O'Brien, T., Katusic, Z. S., Fu, A., Nygren, J., Singh, R., et al. (2002). Dietary antioxidants preserve endothelium dependent vasorelaxation in overfed rats. Atherosclerosis, 161, 327-333.
48. Suarez, I., Bodega, G., & Fernandez, B. (1998). Changes in glial fibrillary acidic protein immunoreactivity in response to experimental hepatic encephalopathy in the rat hippocampus. Restorative Neurology and Neuroscience, 12, 49-54.
49. Suda, O., Tsutsui, M., Morishita, T., Tanimoto, A., Horiuchi, M., Tasaki, H., et al. (2002). Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficientmice. Circulation, 106, 1729-1735.
50. Sun,Y.,Oberley, L.W.,&Li,Y. (1988).Asimplemethod for clinical assay of superoxide dismutase. Clinical Chemistry, 34, 497-500.
51. Ueno, M., Sakamoto, H., Tomimoto, H., Akiguchi, I., Onodera, M., Huang, C. L., et al. (2004). Blood-brain barrier is impaired in the hippocampus of young adult spontaneously hypertensive rats. Acta Neuropathologica, 107, 532-538. (Pubitemid 38779704)
52. Vink, H., Constantinescu, A. A., & Spaan, J. A. (2000). Oxidized lipoproteins degrade the endothelial surface layer: Implications for platelet-endothelial cell adhesion. Circulation, 101, 1500-1502.
53. Wachtel, M., Bolliger, M. F., Ishihara, H., Frei, K., Bluethmann, H., & Gloor, S. M. (2001). Down-regulation of occludin expression in astrocytes by tumour necrosis factor (TNF) is mediated via TNF type-1 receptor and nuclear factor-kappa B activation. Journal of Neurochemistry, 78, 155-162.
54. Yasmineh, W. G., Kaur, T. P., Blazar, B. R., & Theologides, A. (1995). Serum catalase as marker of graft-vs-host disease in allogenic bone marrow transplant recipients: Pilot study. Clinical Chemistry, 41, 1574-1580.